(0.32%) 5 116.33 points
(0.31%) 38 357 points
(0.37%) 15 988 points
(-0.97%) $83.04
(5.36%) $2.03
(0.33%) $2 355.00
(0.54%) $27.69
(4.26%) $961.35
(-0.27%) $0.932
(-0.45%) $10.98
(-0.59%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease...
Stats | |
---|---|
本日の出来高 | 221 867 |
平均出来高 | 777 480 |
時価総額 | 98.32M |
EPS | $-0.280 ( 2021-08-11 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.491 (4.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-05-18 | Berman Robert Andrew | Buy | 3 000 | Common Stock, $0.00001 par value |
2020-07-18 | Duhay Francis | Buy | 62 500 | Common Stock |
2020-07-18 | Duhay Francis | Buy | 100 000 | Stock Option |
2019-06-07 | Biodyne Holding, S.a. | Sell | 684 813 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 4 transactions |
Buy: 165 500 | Sell: 684 813 |
ボリューム 相関
Hancock Jaffe 相関
10 最も負の相関 | |
---|---|
ARDS | -0.91 |
IBRX | -0.895 |
NETE | -0.883 |
HRMY | -0.878 |
ALRS | -0.87 |
RPTX | -0.859 |
VIEW | -0.853 |
MMAC | -0.849 |
LGHL | -0.848 |
FLIC | -0.848 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Hancock Jaffe 相関 - 通貨/商品
Hancock Jaffe 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-546 000 (0.00 %) |
EPS: | $-1.910 |
FY | 2023 |
収益: | $0 |
総利益: | $-546 000 (0.00 %) |
EPS: | $-1.910 |
FY | 2022 |
収益: | $0 |
総利益: | $-525 000 (0.00 %) |
EPS: | $-2.16 |
FY | 2020 |
収益: | $4 252.00 |
総利益: | $4 252.25 (100.00 %) |
EPS: | $-0.0106 |
Financial Reports:
No articles found.
Hancock Jaffe
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。